v.rautio
TL2 Moderator · Trondheim
Contributes reviews on supplier material. Based in Trondheim.
Joined 25 April 2025 · last posted 8d
103 posts, newest first. Showing up to 150.
-
Alcohol: what is documented and what is folklore Replied, post #122 · Practice › Interactions · 20 Jul 2026 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
What a certificate commits its issuer to Replied, post #27 · Analytics › COA interpretation · 14 Jul 2026 · 0 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
The anatomy of a question that gets answered within an hour Replied, post #111 · Start Here › How to Ask · 13 Jul 2026 · 22 likes On post #107 — agreed on the reasoning, with one qualification. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #73 · Analytics › Home & field testing · 11 Jul 2026 · 0 likes Worth separating two things that post #69 runs together. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #2 · Compounds › Tirzepatide · 10 Jul 2026 · 4 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Tracking intake honestly when appetite is absent Replied, post #91 · Nutrition & Training › Protein & intake · 9 Jul 2026 · 3 likes Worth separating two things that post #87 runs together. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #17 · Lounge › Off topic · 1 Jul 2026 · 29 likes Coming back to post #15, because the follow-up matters more than the original answer. Newer drugs and mechanisms: when a new drug launches or a new mechanism is…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #84 · Start Here › Welcome · 30 Jun 2026 · 0 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Travelling with an injectable: documentation and practicalities Replied, post #35 · Access › International · 21 Jun 2026 · 2 likes Worth separating two things that post #31 runs together. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it…
-
Racemisation and why it is invisible to a mass measurement Replied, post #56 · Analytics › Impurities & related substances · 11 Jun 2026 · 13 likes This follows post #53 rather than contradicting it. Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #85 · Evidence › Journal club · 7 Jun 2026 · 2 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Batch numbers that do not match the vial label Replied, post #26 · Sourcing › Red flags · 7 Jun 2026 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: Programming during a large energy deficit Replied, post #11 · Nutrition & Training › Resistance training · 2 Jun 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Request: a per-category review queue Replied, post #9 · Meta › Feature requests · 29 May 2026 · 0 likes Feature scope: some requests are for the site itself (search, filtering, navigation). Some are for the documentation (new topics, different formats). Scope helps…
-
Reading a home test result without over-claiming Replied, post #44 · Analytics › Home & field testing · 16 May 2026 · 0 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #70 · Outcomes › Body composition · 4 May 2026 · 7 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Spreadsheets: an appreciation — what changed since Replied, post #21 · Lounge › Off topic · 17 Apr 2026 · 15 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
Journal club: is percentage weight change the right endpoint? Replied, post #52 · Evidence › Journal club · 9 Apr 2026 · 19 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
[2026 update] What a purity-only report leaves out Replied, post #77 · Sourcing › Independent verification · 3 Apr 2026 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #26 · Practice › Administration · 3 Apr 2026 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #3 · Devices › Syringes & needles · 27 Mar 2026 · 12 likes On the opening post — agreed on the reasoning, with one qualification. Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid,…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #33 · Analytics › Mass spectrometry · 26 Mar 2026 · 0 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Run-in periods and the population they select Replied, post #88 · Evidence › Trials · 26 Mar 2026 · 17 likes On post #84 — agreed on the reasoning, with one qualification. Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #103 · Pharmacology › Pharmacokinetics · 11 Mar 2026 · 0 likes post #102 is right about the mechanism and I think understates the practical bit. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #46 · Analytics › Impurities & related substances · 28 Feb 2026 · 25 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #58 · Regional › UK & Ireland · 28 Feb 2026 · 9 likes Picking up post #55: that is the part I would want checked first. Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only.…
-
Measurement error in a self-reported exposure Replied, post #86 · Evidence › Study critique · 26 Feb 2026 · 26 likes Worth separating two things that post #82 runs together. Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #72 · Practice › Storage & stability · 25 Feb 2026 · 8 likes Worth separating two things that post #68 runs together. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #50 · Analytics › Mass spectrometry · 13 Feb 2026 · 0 likes Picking up post #47: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #35 · Data & Tools › Calculators · 3 Feb 2026 · 24 likes Coming back to post #33, because the follow-up matters more than the original answer. Storage lookup: which conditions (temperature, time) are you considering storing…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #69 · Access › International · 23 Jan 2026 · 18 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #19 · Clinical › Special populations · 21 Jan 2026 · 1 like Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
What a certificate commits its issuer to — one year on Replied, post #5 · Analytics › COA interpretation · 15 Jan 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Specification in the result column: why that is a meaningful error Replied, post #105 · Analytics › COA interpretation · 14 Jan 2026 · 7 likes On post #101 — agreed on the reasoning, with one qualification. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is…
-
A partial dose because the pen emptied mid-injection Replied, post #30 · Practice › Administration · 8 Jan 2026 · 0 likes post #29 is right about the mechanism and I think understates the practical bit. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #19 · Documentation › Wiki requests · 1 Jan 2026 · 0 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Documentation that materially improves an appeal's chances Replied, post #98 · Access › Insurance & coverage · 10 Dec 2025 · 1 like Worth separating two things that post #94 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Journal club: LEADER as the historical anchor Replied, post #11 · Evidence › Journal club · 10 Dec 2025 · 0 likes post #10 is right about the mechanism and I think understates the practical bit. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #25 · Compounds › Tirzepatide · 8 Dec 2025 · 27 likes post #24 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #25 · Practice › Reconstitution · 23 Nov 2025 · 3 likes Coming back to post #23, because the follow-up matters more than the original answer. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #8 · Compounds › Tirzepatide · 20 Nov 2025 · 0 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Lurking for two months before posting: was that the right call? Replied, post #11 · Start Here › Welcome · 17 Nov 2025 · 0 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #96 · Safety › Adverse events · 5 Nov 2025 · 0 likes Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide compounds but possible. Distinguishing true allergy from GI intolerance matters.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #19 · Clinical › Special populations · 25 Oct 2025 · 11 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
Sleep tracking data and its considerable limitations Replied, post #82 · Wellbeing › Sleep · 25 Oct 2025 · 0 likes post #81 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
New subcategory: rationale and scope Replied, post #75 · Meta › Announcements · 21 Oct 2025 · 30 likes Coming back to post #73, because the follow-up matters more than the original answer. Notifications: watching this subcategory means you receive notifications when…
-
Reading an interaction checker output critically Replied, post #24 · Practice › Interactions · 18 Oct 2025 · 0 likes Coming back to post #22, because the follow-up matters more than the original answer. Separation timing versus clinically important interaction: a separation timing…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #47 · Start Here › Welcome · 16 Oct 2025 · 15 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
High-resolution MS on aggregates and what it can see Replied, post #93 · Analytics › Mass spectrometry · 15 Oct 2025 · 0 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
[2026 update] Splitting an overlong document into two Replied, post #37 · Documentation › Wiki requests · 1 Oct 2025 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Compounds this community declines to help with, and why Replied, post #11 · Compounds › Other compounds · 25 Sep 2025 · 8 likes Picking up post #8: that is the part I would want checked first. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite.…
-
What this community means by "a source", in practical terms Replied, post #121 · Start Here › Welcome · 20 Sep 2025 · 0 likes On post #117 — agreed on the reasoning, with one qualification. Nothing here requires expertise. The experienced members here got that way by posting questions, not by…
-
Particulates in a reconstituted solution: identifying the likely source Replied, post #7 · Analytics › Impurities & related substances · 13 Sep 2025 · 0 likes This follows post #4 rather than contradicting it. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #33 · Sourcing › Regulatory · 28 Aug 2025 · 9 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #10 · Start Here › How to Ask · 26 Aug 2025 · 0 likes Picking up post #7: that is the part I would want checked first. Five questions in one post gets you one answer: the easiest one, usually not the one you needed most.…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #30 · Practice › Dosing & titration · 23 Aug 2025 · 0 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #68 · Access › Insurance & coverage · 4 Aug 2025 · 29 likes On post #64 — agreed on the reasoning, with one qualification. Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary…
-
A ten-fold dose error caught before injection — one year on Replied, post #45 · Devices › Syringes & needles · 2 Aug 2025 · 0 likes This follows post #42 rather than contradicting it. Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #33 · Sourcing › Vendor reports · 31 Jul 2025 · 25 likes Worth separating two things that post #29 runs together. Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #46 · Evidence › Journal club · 29 Jul 2025 · 0 likes This follows post #43 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #16 · Evidence › Meta-analyses · 2 Jul 2025 · 19 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #153 · Compounds › Cagrilintide & amylin analogues · 20 Jun 2025 · 31 likes On post #149 — agreed on the reasoning, with one qualification. The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #39 · Devices › Cold chain · 15 Jun 2025 · 12 likes Picking up post #36: that is the part I would want checked first. Shipping container and cold packs: reputable suppliers use insulated containers with cold packs…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #64 · Wellbeing › Mental health · 5 Jun 2025 · 0 likes I read post #62 twice before replying, because I had assumed the opposite. Motivation and expectation: starting with clear motivation and realistic expectations about…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 4 Jun 2025 · 21 likes This follows post #10 rather than contradicting it. Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a…
-
Reading a trial's population section before its results — does this still hold? Replied, post #109 · Evidence › Trials · 16 May 2025 · 0 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #3 · Analytics › COA interpretation · 4 May 2025 · 12 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Certificates issued by the seller versus by a laboratory Replied, post #56 · Analytics › COA interpretation · 22 Apr 2025 · 24 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #5 · Evidence › Journal club · 16 Apr 2025 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #40 · Outcomes › Progress reports · 16 Apr 2025 · 0 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
An orphaned page with no inbound links Replied, post #26 · Meta › Wiki maintenance · 8 Apr 2025 · 0 likes Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the maintainer see the connection.
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #16 · Compounds › Retatrutide · 6 Apr 2025 · 26 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
A report I filed that turned out to be wrong, and the correction Replied, post #5 · Sourcing › Vendor reports · 5 Apr 2025 · 0 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
A promotion I argued against, and why I lost Replied, post #161 · Documentation › Doc review · 4 Apr 2025 · 2 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #9 · marked as the solution · Sourcing › Independent verification · 26 Mar 2025 · 12 likes I read post #7 twice before replying, because I had assumed the opposite. Repeat testing: if you want to verify the same lot a second time, testing with a different…
-
Reading order for a first week here, and what to skip until later Replied, post #26 · Start Here › Welcome · 6 Mar 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: Attributing a new peak: degradation product or excipient? Replied, post #20 · Analytics › Impurities & related substances · 19 Feb 2025 · 0 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #10 · Practice › Reconstitution · 11 Feb 2025 · 0 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #44 · Analytics › Mass spectrometry · 28 Jan 2025 · 12 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #36 · Compounds › Oral incretins · 26 Dec 2024 · 0 likes Worth separating two things that post #32 runs together. Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #41 · Safety › Adverse events · 22 Dec 2024 · 20 likes Severe gastrointestinal events: persistent vomiting, abdominal pain out of proportion, or signs of bowel obstruction warrant urgent evaluation. Mild nausea and…
-
[2026 update] New subcategory: rationale and scope Replied, post #80 · Meta › Announcements · 20 Dec 2024 · 27 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #47 · Evidence › Trials · 20 Dec 2024 · 20 likes This follows post #44 rather than contradicting it. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #65 · Practice › Side effects · 11 Dec 2024 · 11 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #8 · Evidence › Journal club · 18 Nov 2024 · 10 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #64 · Devices › Syringes & needles · 12 Nov 2024 · 0 likes post #63 answers the question as asked. The question underneath it is different. Aspirating before injection: for subcutaneous injection, aspirating (pulling back on…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #29 · Evidence › Journal club · 10 Nov 2024 · 11 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Time to steady state after a dose increase Replied, post #100 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 7 likes post #99 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
US compounding rules and how they changed Replied, post #54 · Regional › North America · 3 Nov 2024 · 0 likes Worth separating two things that post #50 runs together. Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage…
-
Critiquing an observational claim about a class effect Started this topic · Evidence › Study critique · 21 Oct 2024 · 5 likes Posting this under the heading it deserves: Critiquing an observational claim about a class effect Everything below is what sits behind that. Session topic: SCALE ( N…
-
Requesting a page: what makes a good request — what changed since Replied, post #119 · Documentation › Wiki requests · 13 Oct 2024 · 0 likes This follows post #116 rather than contradicting it. Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The…
-
Requesting a page: what makes a good request — what changed since Replied, post #92 · Documentation › Wiki requests · 12 Oct 2024 · 0 likes This follows post #89 rather than contradicting it. Cross-referencing: if you notice two pages that should reference each other but do not, suggest the cross-reference.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #139 · Nutrition & Training › Hydration & electrolytes · 7 Oct 2024 · 0 likes Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #16 · Wellbeing › Mental health · 4 Oct 2024 · 0 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
Coming back to: Deconvolution of a multiply charged envelope Started this topic · Analytics › Mass spectrometry · 23 Sep 2024 · 6 likes On the subject in the title: Deconvolution of a multiply charged envelope Working notes rather than a conclusion. Working through the identity arithmetic and I would…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #54 · Analytics › COA interpretation · 14 Sep 2024 · 23 likes Coming back to post #52, because the follow-up matters more than the original answer. What fields matter on a certificate: lot number matching the vial, test date, the…
-
A page that has drifted out of date and needs a maintainer Replied, post #5 · Documentation › Wiki requests · 27 Aug 2024 · 17 likes Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates that have passed, regulatory changes, new evidence) post a flag so…
-
When to suspect the method rather than the sample Replied, post #6 · Analytics › Method validation · 26 Aug 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #28 · Clinical › Prescriber conversations · 29 Jul 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #30 · Practice › Dosing & titration · 19 Jul 2024 · 2 likes post #29 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Journal club: FLOW and the renal composite, component by component Replied, post #74 · Evidence › Journal club · 16 Jul 2024 · 0 likes post #73 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
-
How this community labels and discusses unrefereed work Replied, post #38 · Evidence › Preprints · 24 Jun 2024 · 15 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Assessing a warm arrival: the decision process — one year on Replied, post #35 · Sourcing › Logistics · 29 May 2024 · 0 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…